8 capital markets & transaction experience

Diabetic Nephropathy

Diabetic Retinopathy

Hypercholesterolemia

Oral Mucositis

Gout

Acute Lymphocytic Leukemia

Bone Metastasis

Brain Cancer

Breast Cancer

Cervical Cancer

Chronic Lymphocytic Leukemia

Endometrial Cancer

Ewing Sarcoma

Gastric Cancer

Gastrointestinal Stromal Tumors

Head And Neck Cancer

Hodgkin Lymphoma

Kidney Cancer

Liver Cancer

Malignant Mesothelioma

Medullary Thyroid Cancer

Melanoma

Multiple Myeloma

Non-Hodgkin Lymphoma

Non-Small Cell Lung Cancer

Ovarian Cancer

Pancreatic Cancer

Testicular Cancer

Thyroid Cancer

Age Related Macular Degeneration

Keratoconjunctivitis sicca (Dry Eye)

Retinal Vein Occlusion

Acute Respiratory Distress

Syndrome

Sepsis

Staphylococcal Infections

Acute Coronary Syndrome

Angina Pectoris

Atrial Fibrillation

Coronary Artery Disease (CAD)

Critical Limb Ischemia

Hypertension

Pulmonary Arterial Hypertension

Acute Pain

Anxiety Disorders

Chronic Pain

Dementia

Diabetic Neuropathy

Obsessive-Compulsive Disorder

Osteoarthritis Pain

Parkinson's Disease

Post-Traumatic Stress Disorder

Restless Legs Syndrome

Schizophrenia

Traumatic Brain Injury

Liver Cirrhosis

Childhood Enuresis

Growth Hormone Disorders

Hyperparathyroidism

Hyperthyroidism

Guillain-Barre Syndrome

Cytomegalovirus

Fungal Infections

Gram-Negative Bacterial Infections

H1N1 Infection

Herpes Zoster

HIV-1 Infection

Human Papillomavirus Infections

Staphylococcus Aureus (MRSA)

Cardiovascular Devices

Prosthetic Heart Valve

Peripheral Vascular Devices

Cardiovascular Monitoring & Diagnostic Devices

Cardiovascular Surgery

Cardiac Rhythm Management

Cardiovascular Prosthetic Devices

Interventional Cardiology

Cardiac Assist Devices

Wound Care Management

Hospital Supplies

Syringes and Needles

Disposable Hospital & Surgical Supplies

Drug Delivery Devices

Inhalation Systems

Needle Free Injections

Infusion Systems

Diabetes Care Devices

Insulin Delivery & Glucose Monitoring

Ophthalmic Devices

Cataract Surgery Devices

Ophthalmic Diagnostic Equipment

Refractive Surgery Devices

ENT Devices

Hearing Implants

Diagnostic Devices

Electrosurgical Devices

Dental Equipment & Accessories

Diagnostic Imaging & MRI Systems

C/T Systems & Mammography Equipment

X-Ray & Ultrasound Systems

Nuclear Imaging Equipment

Contrast Media Injectors

Bone Densitometry

Anesthesia and Respiratory Devices

Anesthesia Machines & Disposables

Respiratory Devices & Disposables

Sleep Apnea Diagnostic Systems

Healthcare IT

Medical Imaging Information Systems

Nephrology and Urology Devices

Renal Dialysis Equipment

Orthopedic Devices

Orthobiologics & Arthroscopy

Joint Reconstruction

Trauma Fixation

Orthopedic Prosthetics

Cranium Maxillofacial Fixation (CMF)

Spinal Surgery

Endoscopy Devices & instruments

Rigid & Flexible Endoscope

In Vitro Diagnostics

Genetic Testing

Clinical Chemistry

Hematology

Immuno Chemistry

Infectious Immunology

Histology And Cytology

Patient Monitoring

Multiparameter Patient Monitoring

Micro-Electromechanical Systems

Non-invasive Blood Pressure Monitors

Neurology Devices

Neurostimulation Devices

Interventional Neurology

CSF Management

Neurosurgical Products

Radiosurgery

Capital Markets

&

Transaction Experience

Research. Investment Banking. Healthcare.

Healthios Experience

2

Has completed multiple strategic

initiatives

BIOSPHERE MEDICAL, INC.

THE UNDERSIGNED HAS ACTED AS EXCLUSIVE

STRATEGIC ADVISOR TO BIOSPHERE

CHEETAH MEDICAL LTD.

THE UNDERSIGNED ACTED AS EXCLUSIVE

ADVISOR TO CHEETAH

Has completed its $20,000,000

Series B financing


sales and marketing initiatives

PATHWAY MEDICAL

TECHNOLOGIES, INC.


STRATEGIC ADVISOR TO PATHWAY

TRIREME MEDICAL, INC.


ADVISOR TO TRIREME


Series D financing

Has sold certain emphysema assets to

THE UNDERSIGNED ACTED AS EXCULSIVE

ADVISOR TO BRONCUS

BRONCUS TECHNOLOGIES, INC.


ADVISOR TO TRIREME

Has entered into an exclusive

distribution agreement with

TRIREME MEDICAL, INC.

Has completed a review of various divestiture

and strategic financing alternatives

NOVADAQ TECHNOLOGIES, INC.


ADVISOR TO NOVADAQ


Series D financing

SYNCARDIA SYSTEMS, INC.

THE UNDERSIGNED ACTED AS ADVISOR

TO SYNCARDIA

Medical Devices & Diagnostics




INNFOCUS, LLC


FINANCIAL ADVISOR TO INNFOCUS

Has completed a structured financing with

Has completed its

Series A financing

NEOCHORD, INC.

THE UNDERSIGNED ACTED AS

FINANCIAL ADVISOR TO NEOCHORD

CARDIOSOUTIONS, INC.


FINANCIAL ADVISOR TO CARDIOSOLUTIONS


Series B financing led by

THE UNDERSIGNED ACTED AS FINANCIAL

ADVISOR TO CLAROS DIAGNOSTICS

Has been acquired by

CLAROS DIAGNOSTICS, INC.


FINANCIAL ADVISOR TO DEERAC FLUIDICS


DEERAC FLUIDICS, INC.



FINANCIAL ADVISOR TO BRONCUS

BRONCUS TECHNOLOGIES, INC.

BOSTON SCIENTIFIC, INC.

THE UNDERSIGNED ACTED AS STRATEGIC

ADVISOR TO CLAYTON DUBILIER & RICE

Has completed a strategic review of its

endoscopy business unit leading to its

decision to optimize strategic alternatives

through a tax-efficient “spin-off”

Has entered a Worldwide

Commercialization Partnership with


FIANCIAL ADVISOR TO VERAX BIOMEDICAL

V BERA X IO MEDICAL

I N C O R P O R A T E D

VERAX BIOMEDICAL, INC.

3

http://www.deerac.com/

http://www.deerac.com/

http://www.labcyte.com/default.aspx

http://www.labcyte.com/default.aspx




4

CLEARCOUNT MEDICAL

SOLUTIONS, INC.


ADVISOR TO CLEARCOUNT MEDICAL SOLUTIONS

Has licensed various IP to Has been acquired by

VENTUS MEDICAL, INC.


ADVISOR TO VENTUS MEDICAL

EXAGEN DIAGNOSTICS, INC.


ADVISOR TO EXAGEN DIAGNOSTICS


Debt financing

CRITICAL PERFUSION, INC.



Has entered into a co-development

agreement with



MIACOM DIAGNOSTICS

Has completed its equity financing from

NANOMIX, INC.


ADVISOR TO NANOMIX


Equity financing by strategic and

financial investors

Has completed a

Strategic Investment by

BIOMERIX, INC.


STRATEGIC ADVISOR TO BIOMERIX



ALPHA THERAPEUTICS, INC



ADVISOR TO MORGAN STANLEY

An operating division of

BAYER PLASMA, GmBH





Cerberus, LLC

SORBENT THERAPEUTICS, INC.


ADVISOR TO SORBENT

Has completed its spinout from

Dow Chemical

BioPharmaceuticals


Series A financing

PINNACLE BIOLOGICS, INC.


FINANCIAL ADVISOR TO PINNACLE

CORIUM INTERNATIONAL, INC.


ADVISOR TO CORIUM INTERNATIONAL

Has issued $35 million in

Interest-Bearing High Yield Securities


FINANCIAL ADVISOR TO INSPIRATION

$259,000,000

Completed a strategic partnership with

INSPIRATION

BIOPHARMACEUTICALS, INC.

Has completed a global collaboration

with

THE UNDERSIGNED ACTED AS FINANCIAL

ADVISOR TO LIQUIDIA

LIQUIDIA TECHNOLOGIES, INC.


FINANCIAL ADVISOR TO NOVALAR

$65,000,000


NOVALAR PHARMACEUTICALS, INC.

5



BioPharmaceuticals

6


Series C Financing

DICERNA PHARMACEUTICALS, INC.


ADVISOR TO DICERNATHE UNDERSIGNED ACTED AS EXCLUSIVE

ADVISOR TO LIQUIDIA

Has completed a $25 ,000,000 Series

A Financing in conjunction with the

“spin –off” of certain assets and

sciences from Liquidia

ENVISIA THERAPEUTICS, INC.

Has completed a round of financing

IRX Therapeutics

THE UNDERSIGNED ACTED AS ADVISOR

TO IRXTHE UNDERSIGNED ACTED AS FINANCIAL

ADVISOR TO CORIUM

CORIUM INTERNATIONAL, INC.,

$52,000,000

Initial Public Offering


ADVISOR TO KALON

FDBU (a Fujifilm subsidiary) acquires

49% of the total membership interests in

Kalon



7

Diabetes Management

STEADYMED, LTD


FINANCIAL ADVISOR TO STEADYMED

Has issued $10,000,000

Series B Preferred Stock

ING BARING


ADVISOR TO ING BARING

Has completed an investment in

WELLDOC, INC.


ADVISOR WELLDOC


Series A Preferred Stock

BAXTER INTERNATIONAL, INC.


ADVISOR TO BAXTER

Has completed a strategic review of its

dialysis business unit, including a market

study of the Wearable Kidney Market and

the Chronic Kidney Disease Market

WELLDOC, INC.


ADVISOR TO WELLDOC

Has completed a strategic partnership

with

CALIBRA MEDICAL, INC.


FINANCIAL ADVISOR TO CALIBRA


Senior Subordinated Debt



FINANCIAL ADVISOR TO CALIBRA

CALIBRA MEDICAL, INC.

http://www.amsino.com/index.html


http://www.ing.com/group/index.jsp




8

Digital Health

iMEDICA, INC


ADVISOR TO iMEDICA


with

ADVANTEDGE HEALTH SOLUTIONS


ADVISOR TO AHS


initiatives

EPOCRATES, INC.


ADVISOR TO EPOCRATES


initiatives

WELLDOC, INC.


ADVISOR TO WELLDOC



WELLDOC, INC.


ADVISOR TO WELLDOC


with

PULSE SYSTEMS


ADVISOR TO PULSE

Healthios has issued a fairness

opinion in conjunction with the

acquisition of Pulse Systems

SXC HEALTH SOLUTIONS, INC.


ADVISOR TO SXC HEALTH SOLUTIONS

Has expanded its management team and

Board of Directors with the addition of

several leaders with significant experience

in the global healthcare industry

PARTNERS OF THE UNDERSIGNED ACTED AS

PRINCIPALS TO INLIGHT

Has issued

INLIGHT, INC.

$39,000,000


http://www.sxc.com/Default.htm

http://www.sxc.com/Default.htm



9

Medical Surgical Products & Distribution

MOLNLYCKE HEALTHCARE, AG


ADVISOR TO CLAYTON DUBILIER & RICE


REGENT MEDICAL, PLC





FINANCIAL ADVISOR TO SMARTPILL


SMARTPILL, INC.

Has entered into an exclusive distribution

agreement with


FINANCIAL ADVISOR TO QUANTUM OPS

QUANTUM OPS, LLCING BARING


ADVISOR TO ING BARING

Has completed an investment in


ADVISOR TO ORTHOCON

ORTHOCON, INC.

Has completed a comprehensive

review of strategic & financial

alternatives

ALINE

AESTHETICS


ADVISOR TO ALINE AESTHETICS


a wholly owned subsidiary of







10

Renal

FRESENIUS MEDICAL CARE


ADVISOR TO METALMARK CAPITAL

Through the divestiture of certain assets

and the completion of a long-term

product supply agreement, has formed

RMS LIFELINE, INC



ADVISOR TO J.W. CHILDS


SORBENT THERAPEUTICS, INC.


ADVISOR TO SORBENT



DOW CHEMICAL, INC


ADVISOR TO DOW CHEMICAL

Through the “spin –off” of certain

assets and sciences, and through the

contribution of $20 million of capital

from leading institutions, has formed

http://www.davita.com/

http://www.davita.com/



11

Healthcare Services

APOLLO HOSPITAL GROUP INDIA

A portfolio investment of


ADVISOR TO ONE EQUITY PARTNERS

Has appointed the senior management of

NCS HEALTHCARE, INC.



ADVISOR TO PALADIUM EQUITY PARTNERS


ADVISOR TO OSF HEALTHCARE

OSF HEALTHCARE

Has expanded its management team and

Board of Directors with the addition of

several leaders with significant experience

in the global healthcare industry

UPSTREAM REHABILITATION, LLC


ADVISOR TO UPSTREAM REHABILITATION

Has been formed by management

in collaboration with

WELLFOUNT CORP.


ADVISOR TO WELLFOUNT

Has completed its $22,000,000 Debt

and Equity financing

http://www.charterhousegroup.com/index.html

http://www.charterhousegroup.com/index.html

Documents

8 capital markets & transaction experience